Enanta Pharmaceuticals Inc
ENTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001177648
No open-market purchases or sales by Enanta Pharmaceuticals Inc insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $397.2M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Enanta Pharmaceuticals Inc changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 170 | 4 | 155 | −11 |
| Shares | 19.7M | 99.7K | 20.2M | +659.9K (+3.4%) |
| Value | $1.40B | $7.10M | $956.3M | −$436.1M (−31.3%) |
4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Enanta Pharmaceuticals Inc at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 148,216 | $7.01M | 1.40% |
| Marshall Wace, LLP | 50,160 | $2.37M | 0.01% |
| Pictet Asset Management SA | 29,629 | $1.40M | 0.00% |
| Point72 Asset Management, L.P. | 28,700 | $1.36M | 0.01% |
| Jump Financial, LLC | 19,800 | $936.0K | 0.04% |
| Caxton Associates LP | 13,843 | $654.0K | 0.08% |
| Two Sigma Investments, LP | 13,591 | $642.0K | 0.00% |
| PDT Partners, LLC | 11,597 | $548.0K | 0.05% |
| Trexquant Investment LP | 6,252 | $296.0K | 0.01% |
| Quantamental Technologies LLC | 4,334 | $205.0K | 0.09% |
Sold out (21)
Institutions that held Enanta Pharmaceuticals Inc at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Deep Track Capital, LP | 198,730 | $14.1M |
| Stonepine Capital Management, LLC | 119,972 | $8.54M |
| Walleye Capital LLC | 63,046 | $4.49M |
| Granahan Investment Management Inc | 43,414 | $3.09M |
| State of New Jersey Common Pension Fund D | 37,284 | $2.65M |
| LMR Partners LLP | 31,604 | $2.25M |
| Citadel Advisors LLC | 29,972 | $2.13M |
| Allianz Asset Management GmbH | 21,665 | $1.54M |
| Ergoteles LLC | 9,809 | $698.0K |
| Caption Management, LLC | 9,000 | $640.0K |
| Voloridge Investment Management, LLC | 8,140 | $579.0K |
| Teacher Retirement System of Texas | 3,793 | $270.0K |
| Janus Henderson Group PLC | 3,686 | $262.0K |
| Boston Family Office LLC | 2,850 | $203.0K |
| Bollard Group LLC | 383 | $27.0K |
| Parallel Advisors, LLC | 164 | $11.0K |
| TCI Wealth Advisors, Inc. | 70 | $5.00K |
| EverSource Wealth Advisors, LLC | 38 | $3.00K |
| Dark Forest Capital Management LP | 40 | $3.00K |
| Allworth Financial LP | 5 | $0 |
| Glassman Wealth Services | 5 | $0 |
Not filed for Q2 2022 yet (4)
Institutions that held Enanta Pharmaceuticals Inc at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 79,959 | $5.69M |
| Amalgamated Financial Corp. | 8,396 | $598.0K |
| Susquehanna Fundamental Investments, LLC | 7,399 | $527.0K |
| Teachers Retirement System of the State of Kentucky | 3,989 | $284.0K |